RLFTY — MindMaze Therapeutics Holding SA
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1854078 ·
Switzerland
Last close
$0.42
Market Cap
$66.59M
52W High
$1.73
52W Low
$0.42
ADV30
0
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Yahoo Snapshot (yfinance, live)
Total Revenue
$642,000
EBITDA
$-9,143,000
Free Cash Flow
—
Enterprise Value
—
Total Cash
—
Total Debt
—
Shares Out
157,602,044
Trailing EPS
$-0.60
Book Value
$0.31
ROE
-51.6%
ROA
-25.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 642,000 | -10,515,000 | -9,906,000 | 51,530,000 | 13,189,000 | — | -7,208,000 |
| Dec 2024 | 0 | -2,000 | -1,000 | 93,000 | 7,000 | — | -3,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HYFT | MindWalk Holdings Corp. | $66.25M | $1.41 | — |
| TENX | TENAX THERAPEUTICS, INC. | $65.49M | $1.75 | — |
| BOLD | Boundless Bio, Inc. | $68.24M | $3.00 | — |
| MNOV | MEDICINOVA INC | $68.42M | $1.39 | — |
| XBIT | XBiotech Inc. | $69.51M | $2.28 | — |
News headlines (Yahoo Finance, 1h cache)
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
2025-12-23 06:20 · Yahoo
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
2025-12-15 06:20 · Yahoo
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
2025-11-14 17:40 · Yahoo
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
2025-10-29 06:20 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.